Oxford Instruments Regulatory News (OXIG)

Release date: 13 February 2013

Oxford Instruments plc

Interim Management Statement

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today issues an Interim Management Statement which covers the period from 1 October 2012 to date.

The trend seen in the first half of the year has continued with growth in the Nanotechnology Tools sector and continued softness in the Industrial Products sector as reported in our half year statement. The Service sector continues to grow as we integrate our existing business with the Platinum Medical Imaging business that we acquired last year.

Our broad spread of geographies and technologies, and our strong pipeline of new products help us to remain resilient in the current uncertain economic environment. The Board anticipates that Oxford Instruments will continue to make good progress, in line with its expectations for the remainder of the financial year and consistent with its 14 cubed objectives.

On 17 December 2012 the Group announced the acquisition of Asylum Research Corporation ("Asylum Research"), a leading provider of Scanning Probe Microscopes (SPM) for an initial debt free, cash free consideration of US$32.0 million with a deferred element of up to US$48.0 million payable over three years dependent on its performance over that period.

Save as described in this statement, there has been no significant change in the financial position of the Group in the period.

- Ends -

Enquiries:

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

MHP Communications Tel: 020 3128 8100

Rachel Hirst / Ian Payne

Issued for and on behalf of Oxford Instruments plc

Notes to Editors  

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. It provides solutions needed to advance fundamental physics research and its transfer into commercial nanotechnology applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

The first technology business to be spun out from Oxford University over fifty years ago, Oxford Instruments is now a global company with over 1900 staff worldwide and is listed on the FTSE250 index of the London Stock Exchange (OXIG).  Its objective is to be the leading provider of new generation tools and systems for the research and industrial sectors.

This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra high vacuum environments, Nuclear Magnetic Resonance, X-ray, electron and optical based metrology, and advanced growth, deposition and etching.

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health.